Top Story

FDA designates Neutrolin as QIDP

January 29, 2015

The FDA has designated a novel formulation as a qualified infectious disease product, for the prevention of catheter-related bloodstream infections for oncology, hemodialysis and ICU patients.

The formulation (Neutrolin, CorMedix) contains taurolidine, citrate and heparin 1,000 u/mL, and also is a preventive agent for thrombosis and biofilm, according to a company press release. The formulation also received fast track designation in early January.

In the Journals

Influenza vaccination rates low among nursing home HCWs

January 29, 2015
Researchers from the Rollins School of Public Health at Emory University have found low rates of influenza vaccination among health care workers at nursing…
Pranita Tamma In the Journals

Piperacillin-tazobactam appeared inferior to carbapenems for ESBL bacteremia

January 28, 2015
Treatment with piperacillin-tazobactam appears inferior to carbapenems for treatment of extended-spectrum beta-lactamase–producing bacteria in the blood…
In the Journals

Novel polymer coating reduced catheter's bacteria spread

January 23, 2015
An inexpensive synthetic coating could reduce the presence of bacteria on biomedical devices, according to recently published data. Researchers from the University…
More News Headlines »

Antimicrobial stewardship: 5 things you should know

January 21, 2015
The CDC estimated that every year, 2 million people will become ill with an antibiotic-resistant infection, of which…
More »
Meeting News Coverage Video
thumbnail for video 3843426785001

'Wake Up and Breathe' protocol decreased VAEs

October 17, 2014
PHILADELPHIA — Deverick Anderson, MD, MPH, associate professor of medicine at Duke University, discusses results…
More »